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Escherichia coli sequence type 131 (ST131) is a globally dissemi-
nated, multidrug resistant (MDR) clone responsible for a high pro-
portion of urinary tract and bloodstream infections. The rapid
emergence and successful spread of E. coli ST131 is strongly asso-
ciated with several factors, including resistance to fluoroquino-
lones, high virulence gene content, the possession of the type 1
fimbriae FimH30 allele, and the production of the CTX-M-15 ex-
tended spectrum β-lactamase (ESBL). Here, we used genome se-
quencing to examine the molecular epidemiology of a collection of
E. coli ST131 strains isolated from six distinct geographical loca-
tions across the world spanning 2000–2011. The global phylogeny
of E. coli ST131, determined from whole-genome sequence data,
revealed a single lineage of E. coli ST131 distinct from other extra-
intestinal E. coli strains within the B2 phylogroup. Three closely
related E. coli ST131 sublineages were identified, with little as-
sociation to geographic origin. The majority of single-nucleotide
variants associated with each of the sublineages were due to
recombination in regions adjacent to mobile genetic elements
(MGEs). The most prevalent sublineage of ST131 strains was char-
acterized by fluoroquinolone resistance, and a distinct virulence
factor and MGE profile. Four different variants of the CTX-M
ESBL–resistance gene were identified in our ST131 strains, with
acquisition of CTX-M-15 representing a defining feature of a dis-
crete but geographically dispersed ST131 sublineage. This study
confirms the global dispersal of a single E. coli ST131 clone and
demonstrates the role of MGEs and recombination in the evolution
of this important MDR pathogen.
bacterial evolution | genomics | phylogeography | genomic epidemiology
Many multidrug-resistant (MDR) bacterial strains are nowrecognized as belonging to clones that originate in a spe-
cific locale, country, or even globally. Escherichia coli sequence
type 131 (ST131) is one such recently emerged and globally
disseminated MDR pandemic clone responsible for community
and hospital-acquired urinary tract and bloodstream infections.
E. coli ST131 was identified in 2008 as a major clone linked
to the spread of the CTX-M-15 extended-spectrum β-lactamase
(ESBL) resistance (1–3). Since then, E. coli ST131 has also been
strongly associated with fluoroquinolone resistance, and core-
sistance to aminoglycosides and trimethoprim-sulfamethoxazole
(4–6). Alarmingly, strains of E. coli ST131 resistant to carbape-
nems have also been reported (7, 8), further limiting treatment
options for this clone.
E. coli ST131 belongs to the B2 phylogenetic subgroup I, with
most isolates characterized as serotype O25b:H4 (1). Epidemi-
ology studies using pulse-field gel electrophoresis (PFGE) have
demonstrated that E. coli ST131 strains exhibit diversity, with
some dominant PFGE pulsotypes including the UK epidemic
strain A (9) and pulsotype 968 (10, 11) widely distributed across
the globe. More recently, a typing scheme using the type 1 fim-
briae fimH adhesin gene revealed that a large subclonal lineage
of E. coli ST131 strains possess the FimH30 allele, which is also
associated with specific mutations in the gyrA and parC genes
that confer resistance to fluoroquinolones (12).
Several whole genome (13–16) and PCR (1, 17–20) studies
have revealed that E. coli ST131 strains possess a variable
complement of genes encoding established virulence factors
commonly associated with extraintestinal pathogenic E. coli
(ExPEC). Indeed, few virulence genes appear to be uniformly
present in E. coli ST131 and, thus, it is likely that differences
in virulence gene content contribute to the variable virulence
potential that has been reported. For example, although some
ST131 strains cause rapid death in a mouse sepsis infection
model (21), this phenotype is not consistent among all strains
(22). The E. coli ST131 strain EC958, which is a representative
of the FimH30-fluoroquinolone resistant subgroup, has been
characterized at the molecular level (15). E. coli EC958 contains
an insertion in the type 1 fimbriae regulator gene fimB (15) that
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is also common to other strains in the FimH30 subgroup (23)
and colonizes the mouse bladder in a type 1 fimbriae-dependent
manner (15). In mice, E. coli EC958 establishes acute and chronic
urinary tract infection (UTI), forms intracellular bacterial com-
munities in the bladder (24), and causes impairment of ureter
contractility (25). E. coli EC958 is also resistant to the bactericidal
action of human serum (26).
The rapid global dissemination of E. coli ST131, combined
with its MDR phenotype and the lack of new antimicrobial drugs
in the developmental pipeline, highlights the urgent need to un-
derstand this pathogen and combat its spread. Here, we sequenced
the genomes of 95 E. coli ST131 strains from six geographical
regions (isolated from 2000 to 2011) to examine the spatial and
temporal relationships of E. coli ST131. Our data supports the rapid
and recent global dispersal of E. coli ST131 as a single clone.
Results and Discussion
A Global Collection of E. coli ST131 Strains. A collection of 99 E. coli
strains defined as ST131, using a described PCR test specific
for the O25b rfb gene and allele 3 of the pabB gene (27), were
isolated between 2000 and 2011 from six countries (Australia,
Canada, India, Spain, United Kingdom, New Zealand) (Dataset
S1). The strains were obtained from several clinical sources and
included isolates from urine (n = 53), blood (n = 21), peritoneal
fluid (n = 1), abdominal abscess (n = 1), surgical wound (n = 2),
and rectal swabs (n = 11). The strains were selected with an
endeavor to encompass diversity with respect to geographic or-
igin, date of isolation, and clinical source. The strains possessed
a range of antibiograms, including variable resistance to ami-
noglycosides, second and third generation cephalosporins, fluo-
roquinolones, penicillins, and sulfonamides (Dataset S1). All
strains were sequenced by using the Illumina HiSeq, assembled
using Velvet, and in silico multilocus sequence typing (MLST)
was performed to confirm the sequenced strains were ST131.
Four strains originally defined as ST131 by rfb and pabB PCR
actually belonged to ST95 (Dataset S1), thus reducing the final
number of ST131 strains examined to 95.
Rapid Global Dispersal of E. coli ST131 as a Single Clone. Phylo-
genetic analysis of the 95 E. coli ST131 strains was carried out
by using whole genome alignment and single-nucleotide poly-
morphism (SNP) analysis using the completely sequenced ST131
representative strain SE15 (13). A maximum likelihood (ML)
tree built using all 142,750 SNPs confirmed that all ST131 strains
belonged to phylogroup B2, subgroup I and showed that ST131
clustered into three well-supported clades that we refer to as
A, B, and C (SI Appendix, Fig. S1A). ML trees based on the
3,186,979-bp core alignment of the assembled sequence data
supported this topology (SI Appendix, Fig. S2A). Recombination
is the primary contributor to interclade diversity with only 70
nucleotide substitutions found to distinguish clades B and C
after removal of recombinant regions (Fig. 1A and Dataset S2).
Neither temporal nor geographical clustering between the major
clades could be observed (Fig. 1A); however, each clade is
comprised of at least two well-supported sublineages and smaller
clusters of closely-related strains that exhibit some geographical
association (Fig. 1B and Dataset S2). This data suggested an
evolutionary history more complex than a standard geographical
clonal expansion, as exemplified by many occurrences of nearly
identical strains isolated in different countries and continents
and over different periods of time. Similar phylogeographic
patterns have been observed for other successful MDR global
lineages such as Staphylococcus aureus ST239 and the PMEN1
pneumococcal lineages (28, 29), whereas a contrasting exam-
ple of clonal expansion with more defined geographical clus-
tering has been reported for Shigella sonnei (30).
ST131 clade A contains the previously-sequenced SE15 strain
and is the most divergent clade (∼7,000 and ∼8,900 SNPs from
clades B and C, respectively) characterized by the fimH41 allele
and different gyrA and parC variants. ST131 clade B is very similar
to clade C (distinguished by ∼2,900 SNPs) and is characterized by
an intact fimB, the fimH22 allele, and gyrA and parC variants that
are consistent with their fluoroquinolone sensitivity (Fig. 1A and
Dataset S1). ST131 clade C strains make up 79% of the ST131
strains sequenced in this study and are distinguished by possession
of the fimH30 allele and the fluoroquinolone resistance alleles
gyrA1AB and parC1aAB (Fig. 1A). All but one of the clade C
strains contained an insertion within the fimB gene as we originally
observed in the clade C strain EC958 (15). These isolates were
collected in six countries from 2000 to 2011, indicating that the
dominant clade C ST131 lineage originated from a single clone
before the year 2000 (Fig. 1A). Although we cannot rule out the
possibility of a bias in our strain collection, we note that the
dominant group among another large collection of ST131 strains
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Fig. 1. Phylogenetic relationship of ST131 strains. (A) ML phylogram with
triangles indicating bootstrap support of >90% from 1,000 replicates. The
tree is rooted by using the outgroup phylogroup D strain UMN026; branch
lengths correspond to the number of SNPs difference (scale bar bottom left).
The phylogram was built from 119,514 substitution-only SNPs determined by
read-mapping using E. coli SE15 as reference excluding recombinant regions,
as defined by BRATNextGen analysis (34). The taxa labels for sequenced
ST131 strains are colored red (clade A), orange (clade B) and green (clade C).
Previously sequenced reference strains are colored black. Colored circles next
to each strain correspond to country and year of isolation (see key). Squares
indicate allelic profiling for fimH, parC, gyrA, and CTX-M (see key). A missing
square indicates the gene is absent. (B) Several well-supported subclades are
evident in the ST131 phylogeny, with the CTX-M-15 gene confined to the
second subclade of clade C. The topology-only cladogram (not to scale)
corresponding to the phylogram in A is shown in gray, with node support
of >90% depicted as gray diamonds. The number of SNPs that define clade
C and sublineages C1 (Upper) and C2 (Lower) are shown below relevant
branches (nonsynonymous, synonymous, intergenic); refer to Dataset S2 for
full list of SNPs and consequences.
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was also found to share the same fimH30-gyrA1AB-parC1aAB
allelic profile (12).
Analysis of the density of all SNPs along the SE15 reference
chromosome revealed a nonhomogeneous distribution, with
many core-genome regions associated with a density ∼8.5-fold
higher than the expected average (Fig. 2). Because discrete
regions with a high-density of SNPs may be the result of re-
combination events, as opposed to mutational hotspots (31, 32),
we inferred the recombination across ST131 genomes by using
a Bayesian clustering approach that was previously successfully
applied to S. aureus and Streptococcus pneumoniae (33, 34). We
found that recombination has introduced 76.6% of the 16,424
SNPs and 2,050 small indels that differentiate the strains within
the ST131 lineage (SI Appendix, Fig. S3 and Dataset S3). Phylo-
genetic analysis using only SNPs found in recombinant regions
also clustered the ST131 strains into the same three-clades
structure (SI Appendix, Figs. S1B and S2B). Overall these results
reflect the significant role that recombination has played in
shaping the three major ST131 lineages with subsequent point
mutations driving the fine-scale diversity within each clade.
Antibiotic Resistance Is Associated with ST131 Clade C. Besides the
major contribution of recombination events to the between-clade
diversity of ST131, we also observed differences in the distribu-
tion of SNPs between recombinant and nonrecombinant regions
(Fig. 2). SNP density across all strains combined was higher in
recombinant regions with an estimated 1.19 × 10−2 SNPs per site
compared with 1.39 × 10−3 SNPs per site in nonrecombinant
regions. Despite the lower density of SNPs, nonrecombinant
regions were characterized by a relatively higher ratio of non-
synonymous to synonymous SNPs (0.05 and 0.07 SNPs per ki-
lobase, respectively) compared with recombinant regions (0.2
and 0.89 SNPs per kilobase, respectively). This difference was
significant (χ2 = 1,045.8, P < 0.00001) and is consistent with a
pairwise comparison of ST131 clade A and clade C strains (23).
Fluoroquinolone resistance is one of the major determining
features of the ST131 clone and is associated with point muta-
tions in the gyrA and parC genes (12) (Fig. 1). The three major
gyrA alleles found in our ST131 dataset were attributed to ver-
tically transmitted point mutations, with unique gyrA mutations
also found in clade A strain S5EC (A669T) and clade C strain
B36EC (Q453R), respectively. In contrast, the parC1aAB allele
was introduced into clade C via recombination, replacing the
parC1 allele and surrounding Rec_089 region that is conserved in
most clade A and B strains (Dataset S3). Multiple, overlapping
recombination events continue to shape the ST131 lineage as
evidenced by two independent replacements of Rec_089 in
subgroups of clade A (encompassing parC2) and clade B (parC3A),
with a further two partial replacements of a 1.8-kb Rec_089
subfragment immediately upstream of parC in two clade C
strains (S101EC and S113EC). Among the 34 nonsynonymous
and nonrecombinant substitutions that define clade C, we could
map nine to crystal structures of homologs, several of which
encode amino acid changes that may impact their function (SI
Appendix, Fig. S5 and Dataset S2). For example, there is a
mutation in the gene encoding the MukB chromosome partition
protein, a known interacting partner of ParC (35). In addition to
established fimH, parC and gyrA mutations in clade C strains, our
identification of further genes with clade C-specific mutations
paves the way for more targeted investigations to identify key
evolutionary events that underpin the success of E. coli ST131.
Among the SNPs that have arisen in individual ST131 clade C
strains or subgroups, there are a number within potential anti-
biotic resistance genes that may have been selected in response
to antibiotic treatment (Dataset S2). Each ST131 clade C strain
(minus NA114) has between 0 and 50 (mean = 13, SD = 11)
unique, nonrecombinant SNPs, 49% of which are nonsyno-
nymous. There are numerous examples of nonsynonymous SNPs
within genes that encode homologs of multidrug resistance
proteins or other putative transporters that may affect antimi-
crobial uptake or efflux (Dataset S2). There are also several SNPs
in genes encoding penicillin-binding proteins (e.g., ECSF_2363/
PBP1C, ECSF_0094/PBP3), other cell wall modifying enzymes
(e.g., ECSF_2495 lytic murein transglycosylase B) and examples of
cell division genes (e.g., ECSF_2198), or essential genes that may
be important for intrinsic resistance development. Although the
majority of ST131 clade C SNPs are unique to the strain in
which they are found, or exhibit patterns of descent consistent
with the inferred phylogeny, we identified genes in which the
same mutation appeared to have been acquired independently
(Dataset S2). For example, the dihydrofolate reductase gene
(ESCF_0053) acquired the trimethoprim resistance L28R
mutation in two phylogenetically separated clade C strains (S116EC
and S11EC), with several other nonsynonymous mutations in
this gene present in different strains.
The majority of clade C strains also possess the CTX-M-15
gene (36 of 42 strains in sublineage C2), with seven other clade C
strains containing different CTX-M alleles (3, 14, or 27) (Fig. 1A
and Dataset S1). The CTX-M-15–positive strains cluster
within a discrete, but temporally and geographically dispersed,
sublineage within clade C (Fig. 1B). Although the pattern of
CTX-M-15 distribution within this sublineage is suggestive of
an ancestral acquisition of the CTX-M-15 gene and subsequent
loss by some individual strains, this allele does not associate
with any particular plasmid incompatibility group defined by
sequence-based typing (SI Appendix, Fig. S4). Furthermore, the
CTX-M-15 gene is found on assembled contiguous fragments
(contigs) ranging in size from 1.4 kb to 10 kb with variable
adjacent gene content (many of which have been previously
identified on plasmids), suggesting that the CTX-M-15 gene has
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Fig. 2. Distribution of ST131-only core SNPs in recombinant versus nonrecombinant regions. (A) Comparison of the linear genome arrangement of the clade
C strain EC958 (Upper) and the clade A strain SE15 (Lower). Solid dark-blue lines between EC958 and SE15 indicate BLAST match of ≥99% nucleotide identity
between the two genomes. Genomic features of interest are highlighted for both strains as follows: prophages (pink); ST131 characteristic ROD1, ROD2, and
ROD3 (yellow); previously characterized genomic islands (blue); and other regions of interest (turquoise). Labels refer to the ST131-characteristic regions
defined in the genome of EC958 (15). (B) Heatmap showing the density of 16,424 ST131-only core SNPs along the SE15 chromosome: Syn_NR (synonymous,
nonrecombinant); NSyn_NR (nonsynonymous, nonrecombinant); Syn_R (synonymous, recombinant); and NSyn_R (nonsynonymous, recombinant). ST131-only
core SNPs were defined as bases called from the mapping data in all strains of the dataset with polymorphisms specific to the ST131 lineage. Recombinant
region coordinates were delineated by using BratNextGen. The SNP density heatmap with (number of SNPs per 1 kbp nonoverlapping bin) is indicated by the
color key. The x axis at the bottom of the figure represents the SE15 reference chromosome coordinates.
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been independently acquired several times or that it has trans-
located between different plasmids or the chromosome. Both
scenarios are consistent with previous reports of different
types of ST131 plasmids that harbor CTX-M-15 (37).
E. coli ST131 Contains Many ExPEC-Associated Genes. The comple-
ment of virulence-associated genes was determined in the 95
E. coli ST131 strains by examining for the presence of genes
encoding chaperone-usher (CU) fimbriae (38), autotransporter
(AT) proteins (39), siderophore receptors (40), toxins, colicins
(41), and other genes often assessed by PCR in ExPEC (1) (SI
Appendix, Fig. S6). The E. coli ST131 strains contained genes
encoding type 1, Mat (ECP), Yde, ECSF_0166, EC958_4610,
and Yeh fimbriae; other CU fimbriae genes including Afa and P
fimbriae were variable. The complement of AT-encoding genes
was highly conserved, with most strains containing genes encoding
antigen 43, UpaB, UpaC, YfaL, and Sat. The ECSF_4014 AT
gene was uniquely present in E. coli ST131 strains. Most E. coli
ST131 strains contained a number of genes associated with iron
acquisition; of note, the Yersiniabactin receptor (ECSF_1835)
was found to be widely prevalent but highly diverse with 17
independent substitutions (14 nonsynonymous) confined to
clade B and C strains, strongly suggesting that, like fimH, this
gene may be under positive selection. Approximately 15% of
E. coli ST131 strains contained genes encoding the HlyA and
Cnf1 toxins. In all but clade C strain S115EC, these genes were
colocated on the chromosome, which is consistent with their
presence on the same genomic island in other ExPEC strains
such as CFT073. In general, 131 UPEC-specific genes present
in CFT073, UTI89, 536, and F11 (42) were also conserved, with
only the gene encoding the putative regulator c0765 absent from
all ST131 strains.
Diversity Within the ST131 Lineage Is Primarily due to Mobile Genetic
Elements and Recombination of Associated Regions. E. coli ST131
strain EC958 contains several mobile genetic elements (MGEs)
and other genomic regions not found in completely sequenced
non-ST131 UPEC strains (i.e., CFT073, 536, UTI89, UMN026,
IAI39), including seven prophage elements (Phi1-7), the Flag-2
lateral flagellar locus, the O-antigen loci, the ratA-like toxin
encoding gene, the type VI secretion locus, the capsular locus,
and four genomic islands (GI) in chromosomal integration hot-
spots (GI-pheV, GI-selC, GI-leuX, and GI-thrW) (15). The ma-
jority of these regions were highly conserved in strains from clade
C but were fully or partly absent in strains from clades A and B
(Fig. 3 and SI Appendix, Fig. S6). Exceptions included the Phi6,
GI-selC, and capsular loci regions, which were not exclusively
associated with a particular clade, suggesting a more complex
evolutionary history. The Flag-2 locus was completely absent in
strains from clade A and in four Spanish strains of clade B
(HVM277, HVM52, HVM2044, HVM2289), replaced by the
fhiA-mbhA scar found in E. coli K12 strains (43). Interestingly,
these four Spanish strains form a discrete sublineage (Fig. 1B)
and also lack prophage and genomic islands that are present in
other clade B strains. In contrast to the O25b serotype of most
clade B and C strains, the LPS core biosynthesis region (spe-
cifically wbbJ-rfbE) of clade A strains was the same as in SE15,
which has been reported as serotype O150 (13). Three regions of
difference (ROD) > 10 kb in length were shown to be unique in
ST131 strains EC958 and SE15 (15). Although the functions of
genes encoded by ROD1 are unclear, ROD1 is conserved in all
ST131 strains. Similarly, ROD2 (which contains several sugar
metabolism genes) was also ubiquitous but contained deletions
in at least three ST131 strains (SI Appendix, Fig. S7). ROD3 is
also conserved across all ST131 strains except for clade A. The
absence of several regions within the NA114 genome that are
otherwise present in closely related clade C strains such as S97EC
(Fig. 3) is consistent with the assembly of this genome, which was
performed by concatenating ordered contigs to produce a single
pseudomolecule without gap closure and finishing (14).
A total of 137 regions were defined as recombinant within the
ST131 lineage (Dataset S3), with a clear propensity to be located
adjacent to predicted MGEs (SI Appendix, Fig. S3). These
recombinant regions totalled 0.94 Mb, or nearly one-fifth of the
entire E. coli SE15 genome and include the aforementioned
fimH and parC genes, which are found on recombinant regions
Rec_137 (92.3 kb) and Rec_089 (18.5 kb), respectively. Although
the majority of regions are less than 1,000 bp in length, ∼80% of
the recombinant bases are contained within 24 large recombi-
nant regions that range in size from 10.2 kb to 166.2 kb. We
could define the lineage on which the recombination event oc-
curred in the majority of cases; however, the larger fragments,
such as Rec_088, Rec_089, and Rec_137, have a more complex
evolutionary history with evidence for multiple blocks of different
origin, reflecting sequential, overlapping recombination events
within the same region (SI Appendix, Fig. S3 and Dataset S3).
When considering the repertoire of recombinant regions that
distinguish each clade, clade A was the most distant, with a total
of 0.52 and 0.6 Mb differing from clade B and C, respectively.
Fig. 3. Selected regions of interest in ST131 strains. ST131-characteristic
regions previously defined in the genome of EC958 (15) are shown along the
x axis with strain identifiers listed on the y axis according to the phylogenetic
tree order displayed in Fig. 1A. Regions A–M are shown to scale in order of
their location relative to the SE15 chromosome (Fig. 2) and correspond to: A,
flag2 flagellar region (38.1 kb); B, GI-ThrW genomic island; C, ROD1; D, Phi1
prophage; E, Phi2 prophage; F, Phi3 prophage; G, ROD2; H, Phi4 prophage; I,
Phi5 prophage; J, Phi6 prophage; K, High-Pathogenicity Island; L, cryptic
prophage; M, O-antigen 1 region (wbbJ-rfbE); N, Phi7 prophage; O, RatA-like
region; P, T6SS region; Q, GI-PheV genomic island; R, capsule region;
S, O-antigen2 region; T, GI-SelC genomic island; U, ROD3; V, GI-LeuX. Black
shading indicates a match of ≥95% nucleotide identity in a minimum window
of 200 bp calculated by comparing the query sequence to the assembled
contigs or the consensus from mapped reads for each strain, as implemented
in seqfindr (http://github.com/mscook/seqfindr).
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Fewer recombinant regions distinguish clade B from clade C,
with the majority of differences contained in regions upstream
of Phi3, and upstream and downstream of GI-pheV and GI-leuX,
respectively (Dataset S3).
A striking feature of the recombination distribution along the
chromosome is that the majority of large recombinant regions
were associated with the sites of insertion of prophage and ge-
nomic island MGEs (SI Appendix, Fig. S3). Statistical evaluation
of 10,000 replicates of the Kolmogorov–Smirnov test confirmed
that the distribution of the observed distances between recom-
binant regions and MGEs was significantly negatively skewed
compared with randomly selected regions (K–S test, mean D =
0.370, SD = 0.049, mean P = 6.082 × 10−6, SD = 8.004 × 10−5)
(SI Appendix, Fig. S8). This phenomenon has been observed in
a comparison using the E. coli ST131 SE15 and NA114 genomes,
for which our analysis agrees with 20 of 22 recombination regions
(23), and in other comparisons of closely related E. coli genomes
(44). In contrast, a reduced role for recombination was reported
in a study comparing 12 ST131 genomes and 50 publicly available
E. coli reference genomes (45).
Recombinant Regions Have Shaped the ST131 Lineage. Fimbrial
adhesins and bacterial motility genes were significantly over-
represented in recombinant fragments (SI Appendix, Fig. S9).
A prime example was the fliC-fliY flagellar locus encoded on the
recombinant fragment Rec_051 (ECSF_1762 to ECSF_1776). In
SE15 and other ST131 clade A strains, the fliC allele corresponds
to the H5 serogroup. In contrast, clade B and C strains possess
an H4 fliC allele within Rec_051, a 12.6-kb recombinant frag-
ment that is adjacent to the Phi5 insertion in EC958. The fim
operon containing the type 1 fimbrial fimH gene resides within
Rec_137, which at 92.6 kb is one of the largest and most complex
recombinant fragments within the ST131 lineage (Dataset S3).
The subfragment of Rec_137 that encodes the region fimC to uxuR
displayed characteristic recombination patterns, introducing a
clade-specific fimH allele (fimH41 in clade A, fimH22 in clade B,
and fimH30 in clade C). Interestingly, these three fimH alleles
were also identified as the major signatures in a small collection
of mainly American isolates, and the same recombinant region
was deduced from the comparison of SE15 and NA114 (23). As
observed in EC958 (15), an insertion within fimB was found in
clade C strains, although it is not clear if this insertion was ac-
quired by homologous recombination concomitant with the ac-
quisition of the fimH30 subfragment, or subsequent to this event.
The only exception in our collection was the ST131 clade C
strain S77EC, which contained a large deletion encompassing
part of the 3′ end of the adjacent GI-leuX island (Fig. 3) and the
fim locus.
Several regions containing putative virulence genes, namely
Rec_087 (ECSF_2626 to ECSF_2634) and part of Rec_088
(ECSF_2784 to ECSF_2804), which contain genes related to
a Type 6 Secretion System (T6SS) and a Type 2 Secretion System
(T2SS), respectively, have also undergone gene conversion.
Clade B and C strains carry T6SS alleles that are distinct from
clade A strains. In contrast, the T2SS locus in clade C strains
appears to have been subjected to several independent recom-
bination events, consistent with its location in a recombination
hotspot downstream of the GI-pheV island (SI Appendix, Fig. S3).
Between the T2SS region and GI-pheV, the Rec_088 recombi-
nant fragment also encodes the group II capsule synthesis locus
(ECSF_2771 to ECSF_2783). Several variant region 2 gene
clusters were observed between region 1 (kpsFEDUCS) and
region 3 (kpsTM) of ST131 genomes, consistent with multiple
instances of replacement since divergence of ST131 clades A and
C with corresponding differences in K-antigen serotype (46). As
described above, differences in the LPS core biosynthesis locus
within the 70.3-kb Rec_069 recombinant fragment suggest that
the O25b serotype is also associated with divergence of clades B
and C from clade A (13).
Several less-well characterized genomic regions that could
differentiate clade C strains from other ST131 strains were also
identified. Two regions with the most distinctive recombination
profiles that clearly distinguished all three clades were Rec_131
(ECSF_4099 to ECSF_4159) upstream of GI-leuX, and part
of Rec_137 (ECSF_4277 to ECSF_4338). The Rec_131 region
contains the tamAB genes, which encode a recently described
translocation and assembly module that contributes to the se-
cretion of some AT proteins (47), whereas the Rec_137 region
contains genes associated with salt resistance (osmY), siderophore-
based iron transport (fhuF), and regulation (creBC). When the
impact of recombination on major gene functions independent
of virulence was considered, significant differences were observed
in genes encoding transporters, fructose-mannose metabolism,
histidine metabolism, and the pentose-phosphate pathway (SI
Appendix, Fig. S9). The impact of these sequence changes remains
to be determined.
Conclusion
Our whole-genome phylogenetic analysis indicates that ST131
has arisen from a single progenitor E. coli that diverged into
three sublineages some time before the year 2000 with acquisition
of multiple mobile genetic elements, associated recombination
events, and point-mutations jointly responsible for the emer-
gence of the most prevalent clade C strains. In addition to the
known fimH, fimB, parC, and gyrA alleles that characterize ST131
clade C, we have defined several additional genes and regions
that may be important for adaptive diversification in response to
host or antibiotic resistance pressures. These results also provide
a framework for future PCR-based assays to rapidly classify ST131
strains and monitor their evolution. Further molecular analysis
of the clade defining variants and MGEs identified in this study
will help to elucidate the mechanisms that have led to ST131
colonization of the urinary tract and other clinical sites, and the
rapid global dispersal of this important group of ExPEC.
Materials and Methods
Genome Sequencing and Assembly. Draft genomes were generated by using
100-bp paired-end Illumina HiSeq 2000 reads and assembled with Velvet (48).
Contigs ≥200 bp were ordered against the EC958 draft genome (BioProject:
PRJEA61443) by using Mauve (49). Sequencing reads are available at the
European Nucleotide Archive under study number ERP001354, accessions
in Study ERP001354 (ERS126551–ERS126646) (see Dataset S1 for accession
numbers) with draft genomes available at http://github.com/BeatsonLab-
MicrobialGenomics/ST131_99. See also SI Appendix, SI Materials and Methods.
Genome Analysis. Alignment of the ST131 draft genome assemblies and three
ST131 reference genomes (SE15, NA114, and EC958), plus completely se-
quenced non-ST131 genomes belonging to the E. coli B2 phylogenetic group
(CFT073, UTI89, E2348/69, ED1a, 536, S88, APEC O1), was performed by using
Mugsy (50) and GBLOCKS (51) with a minimum syntenic block of 5 kbp.
Recombination in the ST131 sequences was estimated by using BratNextGen,
which implements a Bayesian clustering algorithm for detection of recom-
binant fragments in closely related sequences (34). See also SI Appendix, SI
Materials and Methods.
Read Mapping and SNP Analysis. Reads from each ST131 isolate and reads
simulated in silico for the 10 complete genomes used in this study were
mapped onto the reference genome SE15 (16) by using SHRIMP 2.0 (52).
Nesoni (www.vicbioinformatics.com/software.nesoni.shtml) was used to
perform SNP calling (conservative default parameters), small indel pre-
diction, and coding effect SNP annotation. In addition, the Nesoni n-way
pairwise comparison method was used to establish the list of all polymorphic
positions conserved in all strains of the dataset. Polymorphic substitution-
only sites were concatenated to produce an alignment that was used for
phylogenetic tree construction. Analysis and visualization of SNP distribution
across the collection were performed by using custom R scripts. See also SI
Appendix, SI Materials and Methods.
Phylogeny. ML phylogenetic trees were estimated by using RAxML 7.2.8 (53)
for the inferred core genome and the SNP alignments (prerecombination
and postrecombination filtering) under the GTR nucleotide substitution
model with a gamma correction for ASRV. Recombination filtering was per-
formed by collapsing the recombinant segment boundaries predicted for each
strain into a unique list of 137 nonoverlapping segments and subsequently
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masking these regions from the alignment (Dataset S3). Support for nodes
was assessed by using 1,000 random bootstrap replicates. See also SI Ap-
pendix, SI Materials and Methods.
Comparative Genomics. Virulence factor profiles, and the presence of other
regions in the draft genomes, were visualized by using seqfindr (http://
github.com/mscook/seqfindr). Query sequences and their source are listed
in Dataset S1 and with sequences available at http://github.com/BeatsonLab-
MicrobialGenomics/ST131_99/. Comparisons between individual genomes
and verification of seqfindr results were performed by using BLAST (54),
Artemis Comparison Tool (55), Easyfig (56), and BRIG (57). See also SI
Appendix, SI Materials and Methods.
ACKNOWLEDGMENTS.We thank Deborah Williamson, Karina Kennedy, and
Hanna Sidjabat for their contribution of strains. We thank the Wellcome
Trust Sanger Institute and Australian Genome Research Facility for sequenc-
ing. This work was supported by Australian National Health and Medical
Research Council (NHMRC) Grants APP1012076 and APP1067455 (to M.A.S.
and S.A.B.). N.K.P. and E.S. were supported by the Australian Infectious
Diseases Research Centre. M.A.S. is supported by Australian Research Council
(ARC) Future Fellowship FT100100662. M.T. is supported by ARC Discovery
Early Career Researcher Award DE130101169. M.D. is supported by NHMRC
Training Fellowship GNT0635250. J.R.-B. and A.P. are supported by the Min-
isterio de Economía y Competitividad, Instituto de Salud Carlos III, the
Spanish Network for Research in Infectious Diseases RD12/0015; Fondo de Inves-
tigación Sanitaria Grants 070190, 10/02021, 10/0195, and 10/00795; and
Junta de Andalucía Grants 0048/2008 and CTS-5259.
1. Nicolas-Chanoine MH, et al. (2008) Intercontinental emergence of Escherichia coli
clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61(2):273–281.
2. Coque TM, et al. (2008) Dissemination of clonally related Escherichia coli strains
expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14(2):
195–200.
3. Lau SH, et al. (2008) Major uropathogenic Escherichia coli strain isolated in the
northwest of England identified by multilocus sequence typing. J Clin Microbiol 46(3):
1076–1080.
4. Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: A pandemic,
multiresistant, community-associated strain. J Antimicrob Chemother 66(1):1–14.
5. Johnson JR, et al. (2010) Escherichia coli sequence type ST131 as an emerging fluo-
roquinolone-resistant uropathogen among renal transplant recipients. Antimicrob
Agents Chemother 54(1):546–550.
6. Uchida Y, et al. (2010) Clonal spread in Eastern Asia of ciprofloxacin-resistant
Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Anti-
microb Agents 35(5):444–450.
7. Peirano G, Schreckenberger PC, Pitout JD (2011) Characteristics of NDM-1-producing
Escherichia coli isolates that belong to the successful and virulent clone ST131. Anti-
microb Agents Chemother 55(6):2986–2988.
8. Morris D, et al. (2012) Detection of OXA-48 carbapenemase in the pandemic clone
Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-
producing Klebsiella pneumoniae. Antimicrob Agents Chemother 56(7):4030–4031.
9. Lau SH, et al. (2008) UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-
lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother
62(6):1241–1244.
10. Johnson JR, et al.; MASTER Investigators (2012) Comparison of Escherichia coli ST131
pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 18(4):598–607.
11. Banerjee R, et al. (2013) Escherichia coli sequence type 131 is a dominant, antimi-
crobial-resistant clonal group associated with healthcare and elderly hosts. Infect
Control Hosp Epidemiol 34(4):361–369.
12. Johnson JR, et al. (2013) Abrupt emergence of a single dominant multidrug-resistant
strain of Escherichia coli. J Infect Dis 207(6):919–928.
13. Toh H, et al. (2010) Complete genome sequence of the wild-type commensal Escherichia
coli strain SE15, belonging to phylogenetic group B2. J Bacteriol 192(4):1165–1166.
14. Avasthi TS, et al. (2011) Genome of multidrug-resistant uropathogenic Escherichia coli
strain NA114 from India. J Bacteriol 193(16):4272–4273.
15. Totsika M, et al. (2011) Insights into a multidrug resistant Escherichia coli pathogen of
the globally disseminated ST131 lineage: Genome analysis and virulence mechanisms.
PLoS ONE 6(10):e26578.
16. Clark G, et al. (2012) Genomic analysis uncovers a phenotypically diverse but genet-
ically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract
infections. J Antimicrob Chemother 67(4):868–877.
17. Gibreel TM, et al. (2012) Population structure, virulence potential and antibiotic
susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob
Chemother 67(2):346–356.
18. Coelho A, et al. (2011) Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-
15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob
Chemother 66(3):517–526.
19. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010) Escherichia
coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli
infections in the United States. Clin Infect Dis 51(3):286–294.
20. Lavigne JP, et al. (2012) Virulence potential and genomic mapping of the worldwide
clone Escherichia coli ST131. PLoS ONE 7(3):e34294.
21. Clermont O, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone
belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother
61(5):1024–1028.
22. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E (2012) Virulence of Escherichia
coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status,
fluoroquinolone resistance, and virulence genotype. Infect Immun 80(4):1554–1562.
23. Paul S, et al. (2013) Role of homologous recombination in adaptive diversification of
extraintestinal Escherichia coli. J Bacteriol 195(2):231–242.
24. Totsika M, et al. (2013) A FimH inhibitor prevents acute bladder infection and treats
chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
J Infect Dis 208(6):921–928.
25. Floyd RV, et al. (2012) Escherichia coli-mediated impairment of ureteric contractility is
uropathogenic E. coli specific. J Infect Dis 206(10):1589–1596.
26. Phan MD, et al. (2013) The serum resistome of a globally disseminated multidrug
resistant uropathogenic Escherichia coli clone. PLoS Genet 9(10):e1003834.
27. Clermont O, et al. (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli
encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64(2):274–277.
28. Croucher NJ, et al. (2011) Rapid pneumococcal evolution in response to clinical in-
terventions. Science 331(6016):430–434.
29. Harris SR, et al. (2010) Evolution of MRSA during hospital transmission and in-
tercontinental spread. Science 327(5964):469–474.
30. Holt KE, et al. (2012) Shigella sonnei genome sequencing and phylogenetic analysis
indicate recent global dissemination from Europe. Nat Genet 44(9):1056–1059.
31. Martincorena I, Seshasayee AS, Luscombe NM (2012) Evidence of non-randommutation
rates suggests an evolutionary risk management strategy. Nature 485(7396):95–98.
32. Touchon M, et al. (2009) Organised genome dynamics in the Escherichia coli species
results in highly diverse adaptive paths. PLoS Genet 5(1):e1000344.
33. Castillo-Ramírez S, et al. (2012) Phylogeographic variation in recombination rates within
a global clone of methicillin-resistant Staphylococcus aureus. Genome Biol 13(12):R126.
34. Marttinen P, et al. (2012) Detection of recombination events in bacterial genomes
from large population samples. Nucleic Acids Res 40(1):e6.
35. Li Y, et al. (2010) Escherichia coli condensin MukB stimulates topoisomerase IV activity
by a direct physical interaction. Proc Natl Acad Sci USA 107(44):18832–18837.
36. Cantón R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Micro-
biol 9(5):466–475.
37. Woodford N, et al. (2009) Complete nucleotide sequences of plasmids pEK204,
pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli line-
ages from the United Kingdom, all belonging to the international O25:H4-ST131
clone. Antimicrob Agents Chemother 53(10):4472–4482.
38. Wurpel DJ, Beatson SA, Totsika M, Petty NK, Schembri MA (2013) Chaperone-usher
fimbriae of Escherichia coli. PLoS ONE 8(1):e52835.
39. Wells TJ, Totsika M, Schembri MA (2010) Autotransporters of Escherichia coli:
A sequence-based characterization. Microbiology 156(Pt 8):2459–2469.
40. Alteri CJ, Mobley HL (2007) Quantitative profile of the uropathogenic Escherichia coli outer
membrane proteome during growth in human urine. Infect Immun 75(6):2679–2688.
41. Bruant G, et al. (2006) Development and validation of an oligonucleotide microarray
for detection of multiple virulence and antimicrobial resistance genes in Escherichia
coli. Appl Environ Microbiol 72(5):3780–3784.
42. Lloyd AL, Rasko DA, Mobley HL (2007) Defining genomic islands and uropathogen-
specific genes in uropathogenic Escherichia coli. J Bacteriol 189(9):3532–3546.
43. Ren CP, Beatson SA, Parkhill J, Pallen MJ (2005) The Flag-2 locus, an ancestral gene
cluster, is potentially associated with a novel flagellar system from Escherichia coli.
J Bacteriol 187(4):1430–1440.
44. Didelot X, Méric G, Falush D, Darling AE (2012) Impact of homologous and non-
homologous recombination in the genomic evolution of Escherichia coli. BMC Genomics
13:256.
45. McNally A, Cheng L, Harris SR, Corander J (2013) The evolutionary path to extra-
intestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction
in detectable recombination within the core genome. Genome Biol Evol 5(4):699–710.
46. Whitfield C (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia
coli. Annu Rev Biochem 75:39–68.
47. Selkrig J, et al. (2012) Discovery of an archetypal protein transport system in bacterial
outer membranes. Nat Struct Mol Biol 19(5):506–510.
48. Zerbino DR, Birney E (2008) Velvet: Algorithms for de novo short read assembly using
de Bruijn graphs. Genome Res 18(5):821–829.
49. Darling AE, Mau B, Perna NT (2010) progressiveMauve: Multiple genome alignment
with gene gain, loss and rearrangement. PLoS ONE 5(6):e11147.
50. Angiuoli SV, Salzberg SL (2011) Mugsy: Fast multiple alignment of closely related
whole genomes. Bioinformatics 27(3):334–342.
51. Castresana J (2000) Selection of conserved blocks from multiple alignments for their
use in phylogenetic analysis. Mol Biol Evol 17(4):540–552.
52. David M, Dzamba M, Lister D, Ilie L, Brudno M (2011) SHRiMP2: Sensitive yet practical
SHort Read Mapping. Bioinformatics 27(7):1011–1012.
53. Stamatakis A (2006) RAxML-VI-HPC: Maximum likelihood-based phylogenetic analy-
ses with thousands of taxa and mixed models. Bioinformatics 22(21):2688–2690.
54. Altschul SF, et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein
database search programs. Nucleic Acids Res 25(17):3389–3402.
55. Carver T, et al. (2008) Artemis and ACT: Viewing, annotating and comparing se-
quences stored in a relational database. Bioinformatics 24(23):2672–2676.
56. Sullivan MJ, Petty NK, Beatson SA (2011) Easyfig: A genome comparison visualizer.
Bioinformatics 27(7):1009–1010.
57. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA (2011) BLAST Ring Image Generator
(BRIG): Simple prokaryote genome comparisons. BMC Genomics 12:402.
Petty et al. PNAS | April 15, 2014 | vol. 111 | no. 15 | 5699
M
IC
RO
BI
O
LO
G
Y
